Section of Vascular and Interventional Radiology, Department of Radiology, University of Chicago Medicine, 5841 S Maryland Ave, MC2026, Chicago, IL, 60367, USA.
Pritzker School of Medicine, University of Chicago, Chicago, IL, USA.
Abdom Radiol (NY). 2021 Mar;46(3):1188-1193. doi: 10.1007/s00261-020-02767-1. Epub 2020 Sep 20.
To compare outcomes following percutaneous cholecystostomy drain placement based on presence or absence of Tokyo Guidelines diagnostic criteria for acute cholecystitis.
Chart review was performed to identify the presence or absence of Tokyo Guidelines diagnostic criteria for acute cholecystitis in 146 patients who underwent percutaneous cholecystostomy between 2012 and 2015. Those who met criteria were compared to those who did not in terms of demographics, laboratory values, drain indwelling time, treatment response, eventual surgical management, and 30-day mortality.
94 patients (64%) met Tokyo Guidelines diagnostic criteria, while 52 did not (36%). Patients within criteria had a shorter mean length of stay (13.5 days vs 18.9 days), were more likely to have a positive gallbladder fluid culture (64.5% vs 28.6%), demonstrated greater response to treatment (87.2% vs 32.7%), and had lower 30-day mortality (6.4% vs 37.8%). There was no significant difference in terms of ICU requirement (38.3% vs 38.9%), mean drain indwelling time (58.8 days vs 65.3 days), eventual laparoscopic cholecystectomy (40.4% vs 25.0%), or open cholecystectomy performed (9.5% vs 9.6%).
Patients outside of Tokyo Guidelines diagnostic criteria for acute cholecystitis were less likely to respond to treatment with percutaneous cholecystostomy and had worse outcomes. Further research may be indicated to better define the indications for percutaneous cholecystostomy placement in this group.
比较经皮胆囊造瘘引流术(PCD)后根据是否存在东京指南(Tokyo Guidelines)急性胆囊炎诊断标准的治疗结果。
对 2012 年至 2015 年期间行 PCD 的 146 例患者的病历进行了回顾性分析,以确定是否存在东京指南急性胆囊炎诊断标准。将符合标准的患者与不符合标准的患者在人口统计学、实验室值、引流管留置时间、治疗反应、最终手术管理和 30 天死亡率等方面进行比较。
94 例(64%)患者符合东京指南诊断标准,52 例(36%)患者不符合。符合标准的患者平均住院时间更短(13.5 天比 18.9 天),胆囊液培养阳性的可能性更高(64.5%比 28.6%),治疗反应更好(87.2%比 32.7%),30 天死亡率更低(6.4%比 37.8%)。两组在 ICU 需求(38.3%比 38.9%)、引流管留置时间(58.8 天比 65.3 天)、最终行腹腔镜胆囊切除术(40.4%比 25.0%)或开腹胆囊切除术(9.5%比 9.6%)方面无显著差异。
不符合东京指南急性胆囊炎诊断标准的患者对经皮胆囊造瘘引流术的治疗反应较差,结局较差。可能需要进一步研究以更好地确定该组患者行经皮胆囊造瘘术的适应证。